世界*實(shí)驗(yàn)材料供應(yīng)商 cellular Technology Ltd正式授權(quán)上海起發(fā)為其中國(guó)代理， cellular Technology Ltd在一直是行業(yè)的*,一直為廣大科研客戶提供zui為優(yōu)質(zhì)的產(chǎn)品和服務(wù),上海起發(fā)一直秉承為中國(guó)科研客戶帶來的產(chǎn)品，的服務(wù)，簽約 cellular Technology Ltd就是為了給廣大科研客戶帶來更加完善的產(chǎn)品和服務(wù),您的滿意將是我們zui大的收獲

 cellular Technology Ltd中國(guó)代理, cellular Technology Ltd上海代理， cellular Technology Ltd北京代理，cellular Technology Ltd廣東代理， cellular Technology Ltd江蘇代理cellular Technology Ltd湖北代理,cellular Technology Ltd天津,cellular Technology Ltd黑龍江代理,cellular Technology Ltd內(nèi)蒙古代理,cellular Technology Ltd吉林代理,cellular Technology Ltd福建代理, cellular Technology Ltd江蘇代理, cellular Technology Ltd浙江代理, cellular Technology Ltd四川代理,

美國(guó)Cellular Technology Ltd (CTL)  www.elispot。。ｃｎ  www.immunospot。。ｃｏｍ
　Cellular Technology Ltd (CTL)是*和zui大的 ELISPOT 技術(shù)解決方案提供商。CTL 由 1996 年在美國(guó) Ohio Case Western Reverse University 大學(xué)發(fā)明新一代 ELISPOT 分析方法的 Paul V. Lehmann 教授所創(chuàng)建。
CTL 是 ELISPOT 技術(shù)的世界*，*創(chuàng)立了當(dāng)代新型 ELISPOT 方法，將 ELISPOT 技術(shù)提升到了精確科學(xué)的高度；*將圖像分析引入到 ELISPOT中，制造出世界上*臺(tái)商業(yè) ELISPOT 分析儀。CTL 15年來一直從事細(xì)胞免疫學(xué)研究，專注于 ELISPOT 領(lǐng)域已經(jīng)超過 10 年的歷史。CTL 是美國(guó) NIH 免疫耐受網(wǎng)*的 ELISPOT 分析實(shí)驗(yàn)室和分析儀提供商。CTL 提供 ELISPOT 分析儀硬件、軟件和相關(guān)服務(wù)。是世界上*能提供整套套 ELISPOT 服務(wù)，包括雙色分析、質(zhì)量控制和大規(guī)模 ELISPOT 協(xié)約服務(wù)在內(nèi)的技術(shù)提供商。敬請(qǐng)，探討 ELISPOT 技術(shù)如何為您的科研、臨床和新藥研制等領(lǐng)域提供有力的幫助。
Cellular Technology Ltd. was formed in 1998 by Dr. Paul V. Lehmann, a Professor at the Case Western Reserve University School of Medicine. 

Dr. Lehmann is a leader in the field of T cell immunology with over 20 high ranking publications dedicated to establishing the scientific basis of cytokine ELISPOT analysis.

Dr. Lehmann developed the original ImmunoSpot technology in order to conduct his own research more effectively. The ImmunoSpot platform is the most frequently referenced in the scientific literature in this field and is widely accepted to be the gold standard. Applications of ImmunoSpot technology include diagnosis and drug discovery for infectious diseases such as HIV and tuberculosis, better understanding and treatment of allergies and autoimmunity, the ability to predict rejection/acceptance responses in organ transplantation and significant improvements in vaccine development and monitoring including for various cancers where post treatment monitoring will be a key part of the therapy.

Dr. Lehmann pioneered the development of tools to accuray and reproducibly measure T cell responses. Dr. Lehmann and CTL designed and constructed the world’s very first ELISPOT reader under US Patent No: 6,410,252 (Methods for Measuring T Cell Cytokines, issued June 25, 2002). The company has been at the forefront of this field ever since.

In 2001, CTL established a laboratory to provide assay services to companies and academic researchers involved in cellular immunology research, drug discovery and drug development. These services include immunogenicity testing, plate scanning and analysis, and ELISPOT assay training.

Within recent years, CTL has expanded its platform to include additional products and services for those in the scientific community. These include cryopreserved PBMC, serum-free media, plaque and colony counters, and expanded contract research services.

Headquartered in Cleveland, Ohio, CTL has expanded to include offices in China, Germany, and Japan.

 CTL has been recognized as the leader in basic science publications about (and clinical application of) ELISPOT assays, instrumentation, software, and reagent solutions. CTL is the only entity that specializes in developing ELISPOT instrumentation, assays, and their implementation in GLP compliant contract research. As such, CTL has been recognized by the Cancer Vaccine Consortium as the ELISPOT reference laboratory and has been awarded by the U.S. National Institutes of Health (NIH) a contract for the validation of the ELISPOT assay for clinical trials.

In recent years, CTL has expanded to include instrumentation for evaluating bioassays as well as reagent solutions including cryopreserved PBMC samples and serum-free media.

Because of its commitment to world-class quality and performance, CTL was awarded the 2005 “Excellence in Exporting” award by the State of Ohio’s Governor’s Office.

Today, CTL’s instrumentation and products are placed in over 30 countries, with over 350 institutes adopting the ImmunoSpot® platform for their immunological research needs.

我們公司zui大優(yōu)勢(shì)是強(qiáng)大的采購，

1：基本什么都能進(jìn)口，血清，抗體，耗材，還有部分限制進(jìn)口的，

2：貨品全，現(xiàn)經(jīng)營(yíng)過700多個(gè)品牌，基本所有生物試劑耗材都可以進(jìn)口，特別是冷偏的產(chǎn)品那就更有優(yōu)勢(shì)，

3：提供加急服務(wù)，一般1-2周到貨，超過時(shí)限加急費(fèi)全免

4：價(jià)格公道，絕大部分價(jià)格有優(yōu)勢(shì)，當(dāng)然不能保證100%產(chǎn)品都是,因?yàn)橐馕吨鴽]有服務(wù).

5：良好的信譽(yù)，大部分客戶我們提供貨到付款服務(wù)，客戶包括清華，北大 交大 復(fù)旦，中山等100多所大學(xué)，ROCHE，阿斯利康，國(guó)藥 ，fisher等500多家公司

6：我們還是Santa,Advanced Biotechnologies Inc, cellular Technology Ltd     ,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, GePromegaridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech；sysy,TriLink BioTechnologies,Inc；worthington-biochem,zyagen等幾十家國(guó)外公司授權(quán)代理。
7：我們還是invitrogen,qiagen,Midland BioProducts Corporationam,sigma;Promega,roche,merck, rnd,BD, GE,pierce,BioLegend等*批發(fā)，歡迎合作。

上海起發(fā)實(shí)驗(yàn)試劑有限公司
：楊建輝
400：
辦公：
*8006

企業(yè):
:http://www.qfbio。。ｃｏｍ/
地址：上海市浦東新區(qū)晨陽路225弄東方現(xiàn)代商業(yè)廣場(chǎng)46號(hào)303室(近東亭路)